LungCancerDiseaseupdate_Sep2013.doc

肺癌文献资料更新 (From 2013//1 to 2013/9/30) Summary for this month (Abstracts:31) Clinical trials: （7） J Clin Oncol.?2013 Sep 3. [Epub ahead of print] (IF:18.038) Randomized, Double-Blind, Placebo-Controlled, Phase III Chemoprevention?Trial?of Selenium Supplementation in Patients With Resected Stage I Non-Small-Cell?Lung Cancer: ECOG 5597. 可切除的I期非小细胞肺癌患者术后补硒的随机双盲安慰剂对照的III期化学预防研究：ECOG 5597 J Clin Oncol.?2013 Sep 16. [Epub ahead of print] (IF:18.038) Prediction of Survival by [18F]Fluorodeoxyglucose Positron Emission Tomography in Patients With Locally Advanced Non-Small-Cell?Lung Cancer?Undergoing Definitive Chemoradiation Therapy: Results of the ACRIN 6668/RTOG 0235?Trial. 局部晚期非小细胞肺癌根治性同期放化疗后行18F-FDG PET的预测价值：ACRIN 6668/RTOG 0235研究结果 Ann Oncol.?2013 Sep 19. [Epub ahead of print] (IF:7.384) Talactoferrin alfa versus placebo in patients with refractory advanced non-small-celllung cancer?(FORTIS-M?trial). 重组人乳铁蛋白-α对比安慰剂治疗难治性晚期非小细胞肺癌 (FORTIS-M?研究) J Thorac Oncol.?2013 Sep 26. [Epub ahead of print] (IF:4.473) Health-Related Quality of Life in Patients with Advanced Nonsquamous Non-Small-Cell?Lung Cancer?Receiving Bevacizumab or Bevacizumab-Plus-Pemetrexed Maintenance Therapy in AVAPERL (MO22089). AVAPERL研究中接受贝伐单抗或贝伐单抗联合培美曲塞维持治疗的晚期非鳞癌非小细胞肺癌患者的健康相关生存质量 Lung Cancer.?2013 Sep 8. pii: S0169-5002(13)00392-9. doi: 10.1016/j.lungcan.2013.08.027. [Epub ahead of print] (IF:3.661) A randomized, phase II?study?of vandetanib maintenance for advanced or metastatic non-small-cell?lung cancer?following first-line platinum-doublet chemotherapy. 晚期或转移性非小细胞肺癌一线含铂双药化疗后续以凡德他尼维持治疗的随机II期研究 Lung Cancer.?2013 Sep 3. pii: S0169-5002(13)00383-8. doi: 10.1016/j.lungcan.2013.08.018. [Epub ahead of print] (IF:3.661) Phase II?trial?of customized first line chemotherapy according to ERCC1 and RRM1 SNPs in patients with advanced non-small-cell?lung cancer. 根据ERCC1 及 RRM1 SNPs为晚期非小细胞肺癌患者定制一线化疗方案的II期研究 Lung Cancer.?2013 Sep 19. pii: S0169-5002(13)00423-6. doi: 10.1016/j.lungcan.2013.09.004. [Epub ahead of print]